UCSF Center for Synthetic Immunology: Tools to Reprogram the Immune System to Combat Cancer
UCSF Center for Synthetic Immunology: Tools to Reprogram the Immune System to Combat Cancer
批准号:
10598362
负责人:
WENDELL A LIM
金额:
$5.93万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-24 至 2024-08-31
关键词:
AddressAntigensBioinformaticsCell TherapyCellsCellular immunotherapyDatabasesEngineeringGene Expression ProfilingGoalsHematopoietic NeoplasmsImmuneImmune systemImmunologistImmunotherapeutic agentMalignant NeoplasmsModelingNormal tissue morphologyPattern RecognitionProcessSafetyScientistSolidSolid NeoplasmSynthetic immunologyTechnologyblood treatmentcell behaviorcell transformationcellular engineeringchimeric antigen receptor T cellscombatcomputer frameworkdesignengineered T cellsimmunoengineeringin vivonanonanomaterialsneoplastic cellnext generationprogramsprototypesmall moleculetooltraffickingtumortumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
UCSF Center for Synthetic Immunology: Tools to Reprogram the Immune System to Combat Cancer
The immune system has emerged as an extraordinarily powerful tool for combating cancer. One of the most
potent agents are engineered T cells programmed to recognize and kill tumor cells. Nonetheless, our ability to
engineer T cells and other immune cells and program them to execute new functions remains relatively primitive.
Aside from CAR T cells for treatment of blood cancers, most engineered cell therapies are risky, potentially highly
toxic, unreliable and often ineffective, especially those cell therapies that attempt to target solid cancers. We
hypothesize that to fulfil the promise of engineered immune cell therapies, we must first transform cell
engineering into a systematic and predictable process; one that uses reliable technology platforms and
principles. Our center will focus on developing a set of sophisticated immune engineering platforms that address
three major needs in next-generation cell therapies:
1) Smart recognition of cancer – develop antigen-pattern recognition circuits that direct immune cells to
optimally recognize solid tumors and discriminate against normal tissue crossreaction, guided by
computational bioinformatic analysis of gene expression patterns.
2) Overcoming the tumor microenvironment – develop multiple classes of cellular circuits that can overcome
or locally remodel immune-suppressive tumor microenvironments to promote highly efficient therapeutic
immune cell trafficking, proliferation, persistence, and tumor-killing activity
3) User-control and safety – to increase control over and safety of these powerful engineered cells, we will
develop a suite of ways to communicate with and control the activity of engineered immune cells in vivo,
including nano/microparticles and small molecules.
To achieve these goals, we have assembled the UCSF Center for Synthetic Immunology, a tightly integrated
interdisciplinary team that encompasses synthetic biologists, immunologists, bio-informaticists, control
engineers, and materials scientists. The products of this center will include publicly available toolkits of parts
and circuits for cell engineering, high-throughput platforms for rapid circuit assembly, new programmable
nanomaterials for controlling immune cell behavior, searchable bioinformatic databases for optimization of tumor
recognition, and computational frameworks for circuit design and for modeling/prototyping in vivo circuit function.
These platforms will help to advance immune cell engineering to be far more reliable, predictable, effective and
safe.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D
-
批准号:10594512
-
项目类别:
-
资助金额:$83.16万
-
财政年份:2022
-
负责人:WENDELL A LIM
-
依托单位:
Ameliorating off-target toxicities of CAR T cells by engineering NOT gates
-
批准号:10657356
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2022
-
负责人:WENDELL A LIM
-
依托单位:
Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D
-
批准号:10436126
-
项目类别:
-
资助金额:$83.08万
-
财政年份:2022
-
负责人:WENDELL A LIM
-
依托单位:
Ameliorating off-target toxicities of CAR T cells by engineering NOT gates
-
批准号:10362126
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2022
-
负责人:WENDELL A LIM
-
依托单位:
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
-
批准号:10094815
-
项目类别:
-
资助金额:$56.32万
-
财政年份:2020
-
负责人:WENDELL A LIM
-
依托单位:
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
-
批准号:10559489
-
项目类别:
-
资助金额:$55.2万
-
财政年份:2020
-
负责人:WENDELL A LIM
-
依托单位:
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
-
批准号:10310406
-
项目类别:
-
资助金额:$14.7万
-
财政年份:2020
-
负责人:WENDELL A LIM
-
依托单位:
Engineering synthetic helper cells that autonomously deliver orthogonal IL-2 to selectively promote therapeutic T cell proliferation in tumors
-
批准号:10285941
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2019
-
负责人:WENDELL A LIM
-
依托单位:
UCSF Center for Synthetic Immunology: Tools to Reprogram the Immune System to Combat Cancer
-
批准号:10598367
-
项目类别:
-
资助金额:$5.93万
-
财政年份:2019
-
负责人:WENDELL A LIM
-
依托单位:
Protein Recognition in Signal Transduction
-
批准号:10460232
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2018
-
负责人:WENDELL A LIM
-
依托单位:
Protein Recognition in Signal Transduction
-
批准号:10214557
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2018
-
负责人:WENDELL A LIM
-
依托单位:
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
-
批准号:9545542
-
项目类别:
-
资助金额:$66.13万
-
财政年份:2014
-
负责人:WENDELL A LIM
-
依托单位:
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
-
批准号:9119791
-
项目类别:
-
资助金额:$66.11万
-
财政年份:2014
-
负责人:WENDELL A LIM
-
依托单位:
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
-
批准号:9319242
-
项目类别:
-
资助金额:$66.13万
-
财政年份:2014
-
负责人:WENDELL A LIM
-
依托单位:
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
-
批准号:8753520
-
项目类别:
-
资助金额:$68.03万
-
财政年份:2014
-
负责人:WENDELL A LIM
-
依托单位:
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
-
批准号:9307796
-
项目类别:
-
资助金额:$51.35万
-
财政年份:2013
-
负责人:WENDELL A LIM
-
依托单位:
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
-
批准号:8642014
-
项目类别:
-
资助金额:$50.9万
-
财政年份:2013
-
负责人:WENDELL A LIM
-
依托单位:
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
-
批准号:9073782
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2013
-
负责人:WENDELL A LIM
-
依托单位:
Harnessing CRISPR for Targeted and Inducible Epigenomic Reprogramming
-
批准号:8735919
-
项目类别:
-
资助金额:$51.21万
-
财政年份:2013
-
负责人:WENDELL A LIM
-
依托单位:
ELUCIDATING THE KINETIC MECHANISM OF SCAFFOLD-MEDIATED MAP KINASE SIGNALING
-
批准号:8363800
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2011
-
负责人:WENDELL A LIM
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: